pharmiweb.com today archive

Amgen (NASDAQ:AMGN) and deCODE Genetics have announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global leader in human genetics, headquartered in Reykjavik, Iceland.

More:

pharmiweb.com today archive

Related Posts

Comments are closed.